MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Cinnarizine

Cinnarizine 15mg tablets

No stability information

Stability notes for Cinnarizine 15mg tablets

There are no stability notes for this medicine.

Suppliers (10) of Cinnarizine 15mg tablets
Cinnarizine 15mg tablets (A A H Pharmaceuticals Ltd)
Cinnarizine 15mg tablets (Alliance Healthcare (Distribution) Ltd)
Cinnarizine 15mg tablets (Almus Pharmaceuticals Ltd)
Cinnarizine 15mg tablets (Medihealth (Northern) Ltd)
Cinnarizine 15mg tablets (Novumgen Ltd)
Cinnarizine 15mg tablets (Phoenix Healthcare Distribution Ltd)
Cinnarizine 15mg tablets (Sigma Pharmaceuticals Plc)
Cinnarizine 15mg tablets (Teva UK Ltd)
Cinnarizine 15mg tablets (Viatris UK Healthcare Ltd)
Stugeron 15mg tablets (McNeil Products Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.